Zinc-finger antiviral protein acts as a tumor suppressor in colorectal cancer
Authors:
- 7 August 2020
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 39 (37) , 5995-6008
Abstract
Avoiding immune destruction is essential for tumorigenesis. Current research into the interaction between tumor and immunological niches complement tumor pathology beyond cancer genetics. Intrinsic host defense immunity is a specialized innate immunity component to restrict viral infection. However, whether intrinsic immunity participates in tumor pathology is unclear. Previously, we identified a zinc-finger antiviral protein ZAP that is commonly downregulated in a panel of clinical cancer specimens. However, whether ZAP has an impact on tumor development was unknown. Here we report ZAP as a genuine tumor suppressor. Pan-caner analysis with TCGA data from 712 patients and large-scale immunohistochemistry in tissue microarrays from 1552 patients reveal that ZAP is prevalently downregulated, and associated with poor survival in liver, colon, and bladder cancer patients. Ectopic over-expression of ZAP inhibits the malignant phenotypes of colorectal tumor by cell cycle arrest. Using RNA immunoprecipitation and RNA decay assays, we demonstrate that ZAP directly and specifically binds to and degrades the transcript of TRAILR4, which in turn represses TRAILR4 expression and inhibits the aggressiveness of colorectal cancer cells. Furthermore, our CRISPR-engineered mice models show that loss-of-function of ZAP synergizes with APC-deficiency to drive malignant colorectal cancer in vivo. Overall, we identify a previously unknown function of the antiviral factor ZAP in colorectal tumorigenesis, linking intrinsic immunity to tumor pathogenetics.Keywords
Funding Information
- National Natural Science Foundation of China (81973342, 81902809, 81872886, 81973347, 81773751, 81872887)
- the Fundamental Research Funds for the Central Universities
- the National Major Scientific and Technological Special Project for "Significant New Drugs Development" during the 13th Five-Year Plan Period
This publication has 45 references indexed in Scilit:
- Inhibition of Hepatitis B Virus Replication by the Host Zinc Finger Antiviral ProteinPLOS Pathogens, 2013
- Zinc Finger Antiviral Protein Inhibits Murine Gammaherpesvirus 68 M2 Expression and Regulates Viral Latency in Cultured CellsJournal of Virology, 2012
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Structure of N-terminal domain of ZAP indicates how a zinc-finger protein recognizes complex RNANature Structural & Molecular Biology, 2012
- Zinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradationProceedings of the National Academy of Sciences, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The Zinc Finger Antiviral Protein Acts Synergistically with an Interferon-Induced Factor for Maximal Activity against AlphavirusesJournal of Virology, 2007
- Inhibition of Filovirus Replication by the Zinc Finger Antiviral ProteinJournal of Virology, 2007
- The zinc-finger antiviral protein recruits the RNA processing exosome to degrade the target mRNAProceedings of the National Academy of Sciences, 2007
- Differential Inhibition of TRAIL-Mediated DR5-DISC Formation by Decoy Receptors 1 and 2Molecular and Cellular Biology, 2006